PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Claire Li

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines1

Latest

Everything in the corpus, newest first.

SEP 4, 2026 · JOURNAL ARTICLE

Applications of Olaparib and Durvalumab Combination Therapy for a Founder BRCA1 Mutation in the Chinese Han Population: A Literature Review

Scholarly Review .

A literature review synthesizing current evidence on PARP inhibitor and immunotherapy combinations for BRCA-mutated cancers, offering clinical perspective rather than reporting original trial data.

Expert GuidanceBRCA Gene Mutations in Cancer Ovarian Cancer Diagnosis and Treatment Claire Li

Study details

DesignNarrative literature review

InterventionLiterature review of olaparib and durvaluma…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support